Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity.

Life sciences - 1 Jul 2021

Posadas-Sánchez Rosalinda, Sánchez-Muñoz Fausto, Guzmán-Martín Carlos Alfonso, Hernández-Díaz Couder Adrian, Rojas-Velasco Gustavo, Fragoso José Manuel, Vargas-Alarcón Gilberto

Abstract excerpt

BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes de COVID-19 disease use as a principal receptor the angiotensin-converting enzyme-2 (ACE2). It has been suggested that dipeptidyl peptidase-4 (DPP4) can be another possible receptor for this virus. The present study aimed to establish if the DPP4 levels and DPP4 polymorphisms are associated with COVID-19 disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Angiotensin-Converting Enzyme 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19

Share to Dipeptidyl Peptidase 4

Share to Gene Frequency

Share to Mexico

Share to SARS-CoV-2

Share to Severity of Illness Index

Source

Open in PubMed Open full text

Identifiers

PMID: 33774023
DOI: 10.1016/j.lfs.2021.119410
PMCID: PMC7989663

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity.PMID 33774023Read ↗

An Updated Review on the Role of Single Nucleotide Polymorphisms in COVID-19 Disease Severity: A Global Aspect.Semantic proximity Read ↗

The ACE rs1799752 Variant Is Associated with COVID-19 Severity but Is Independent of Serum ACE Activity in Hospitalized and Recovered Patients.Semantic proximity Read ↗

In Silico analysis unveils rs2109069 of DPP9 as a potential catalyst for COVID-19 severity and risk of inflammatory symptoms.Semantic proximity Read ↗

ACE2 and TMPRSS2 SNPs as Determinants of Susceptibility to, and Severity of, a COVID-19 Infection.Semantic proximity Read ↗

Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome.Semantic proximity Read ↗

Role of ACE2 and TMPRSS2 polymorphisms on COVID-19 outcome and disease severity in adult patients: A prospective cohort study in a tertiary hospital, Indonesia.Semantic proximity Read ↗

Angiotensin-converting-enzyme insertion/deletion polymorphism, ACE activity, and COVID-19: A rather controversial hypothesis. A case-control study.Semantic proximity Read ↗

Role of ACE, ACE2 gene variants and serum ACE/ACE2 ratio in COVID-19 severitySemantic proximity Read ↗

An observed association between angiotensin-converting enzyme 2 polymorphisms and COVID-19 severity in ChinaSemantic proximity Read ↗

Study on the correlation between DPP9 rs2109069 and IFNAR2 rs2236757 polymorphisms with COVID-19 mortality.Semantic proximity Read ↗

Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease.Semantic proximity Read ↗

COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.